Darwin Global Management, Ltd. 13D and 13G filings for TG Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:45 pm Sale |
2024-09-30 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 0 0.000% |
-4,046,598 (Position Closed) |
Filing |
| 2024-02-14 3:30 pm Sale |
2023-12-31 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 4,046,598 2.700% |
-6,404,643 (-61.28%) |
Filing |
| 2023-04-03 08:00 am Purchase |
2023-03-22 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 10,451,241 7.100% |
10,451,241 (New Position) |
Filing |